SanBio Co. Ltd. | Balance Sheet

Fiscal year is February-January. All values JPY Millions.
2014
2015
2016
2017
2018
2019
Cash & Short Term Investments
439
1,229
7,734
5,561
4,655
12,453
Total Accounts Receivable
1
-
-
17
-
-
Other Current Assets
15
29
458
546
422
606
Total Current Assets
454
1,258
8,191
6,125
5,077
13,059
Net Property, Plant & Equipment
19
18
68
148
101
74
Total Investments and Advances
-
473
-
-
-
829
Intangible Assets
-
-
-
8
5
3
Other Assets
1
6
11
12
10
11
Total Assets
474
1,755
8,271
6,292
5,194
13,976
ST Debt & Current Portion LT Debt
-
100
900
150
67
Income Tax Payable
-
181
185
-
-
Other Current Liabilities
2,437
100
335
397
2,040
Total Current Liabilities
2,437
381
1,420
547
2,107
Long-Term Debt
-
1,100
300
1,150
2,233
Deferred Taxes
-
362
185
-
-
Total Liabilities
2,437
1,842
1,905
1,697
4,340
Common Equity (Total)
1,963
87
6,367
4,595
853
Total Shareholders' Equity
1,963
87
6,367
4,595
853
Total Equity
1,963
87
6,367
4,595
853
Liabilities & Shareholders' Equity
474
1,755
8,271
6,292
5,194

About SanBio Co.

View Profile
Address
St. Luke Tower, 28/F
Tokyo Tokyo 104
Japan
Employees -
Website http://www.sanbio.jp
Updated 07/08/2019
SanBio Co., Ltd. engages in the development and sale of regenerative cells pharmaceuticals. It also provides regenerative therapies for neurological disorders that include stroke, traumatic brain injury, eye diseases, and Parkinson's disease. The company was founded by Keita Mori and Toru Kawanishi in February 2001 and is headquartered in Tokyo, Japan.